CDC Updates Clinical Guidance for Ebola Disease (Orthoebolavirus zairense) (cdc.gov)

• CDC updates clinical guidance for Ebola disease on May 27, 2026
• FDA-approved treatments: Inmazeb and Ebanga only for Zaire ebolavirus
• Ervebo vaccine only approved for Orthoebolavirus zairense
• No approved therapies for Sudan, Taï Forest, and Bundibugyo viruses
• Early supportive care improves outcomes
• Special guidance for pregnant women, neonates, dialysis patients, and survivors

"CDC published updated clinical guidance for Ebola disease on May 27, 2026. The guidance covers assessment, treatment, and infection control for suspect cases. FDA-approved treatments (Inmazeb, Ebanga) and vaccine (Ervebo) are only available for Zaire ebolavirus. No approved therapies exist for other orthoebolaviruses (Sudan, Taï Forest, Bundibugyo). Supportive care is emphasized."